Sign up for E-news! COVID-19 Updates 988: 24/7 LIfeline
Home News Medical Cannabis Program adding anxiety disorder as qualifying condition
David Morgan
575-528-5197 Office
575-649-0754 Mobile

Medical Cannabis Program adding anxiety disorder as qualifying condition

The New Mexico Department of Health’s Medical Cannabis Program announced Tuesday anxiety disorder will be added to the program’s list of qualifying conditions for enrollment starting Jan. 1, 2023.   
The announcement was made at the program’s Medical Cannabis Medical Advisory Board meeting. A petition requesting anxiety disorder be added as a qualifying condition was submitted for consideration at the board’s meeting last March – where the board voted unanimously to support the recommendation Dr. David R. Scrase, Acting Cabinet Secretary for the Department of Health, approved the advisory board’s petition in late November.    
“Anxiety disorder is a debilitating condition that affects as much as 25 percent of New Mexicans. While there are many good medical options for treating anxiety disorder, treatment resistance can affect one out of every three patients,” wrote Dr. Scrase in his decision. “Even though patients may access cannabis without a medical cannabis card through the adult use program, by including anxiety disorder in the list of qualifying conditions, patients would have increased opportunity to discuss with their medical provider how cannabis can be used to alleviate the symptoms of their anxiety disorder.”   
Anxiety disorder is the first new qualifying condition added since June 2019.  
The Medical Cannabis Program was created under the Lynn and Erin Compassionate Use Act. The purpose of this Act is to allow the beneficial use of medical cannabis in a regulated system for alleviating symptoms caused by debilitating medical conditions and their medical treatments. The New Mexico Department of Health administers the program in accordance with the act.  
The full documents outlining the Medical Cannabis Advisory Board’s recommendation as well as the Secretary of Health’s decision can be found online in the Announcements section of
Information about the Medical Cannabis Program, including information for health providers, patients and caregivers can be found on the NMDOH webpage,  

Media Contact

We would be happy to provide additional information about this press release. Simply contact David Morgan at 575-528-5197 (Office) or 575-649-0754 (Mobile) with your questions.

Versión en Español

En un esfuerzo para hacer que nuestros comunicados de prensa sean más accesibles, también tenemos disponibles una versión en español. Por favor presione el enlace de abajo para acceder a la traducción.

El Programa de Cannabis Medicinal incluirá el trastorno de ansiedad entre las condiciones requeridas